|
|
|
California court upholds verdict in Monsanto cancer case
Legal Line News |
2020/07/21 10:50
|
A California appeals court on Monday upheld a groundbreaking verdict that Monsanto’s widely used weed killer caused cancer in a school groundskeeper but the panel also slashed the damage award from $78.5 million to $21.5 million.
The 1st District Court of Appeal said there was evidence to support a California jury’s 2018 decision that “Monsanto acted with a conscious disregard for public safety,” but it reduced the damages to Dewayne Johnson of Vallejo because state law doesn’t allow damages for reduced life expectancy, the San Francisco Chronicle reported.
The original San Francisco Superior Court jury found that St. Louis-based Monsanto had purposely ignored warnings and evidence that glyphosate, the active ingredient in its popular Roundup and Ranger Pro products, causes cancer.
Johnson, then 46, alleged that his non-Hodgkin’s lymphoma was caused by his years of spraying Ranger Pro on school grounds in Benicia.
Jurors awarded Johnson $289.2 million but a judge later reduced the punitive damages, knocking down the total to $78.5 million.
In further reducing the total award, the appellate court ruled 3-0 that state law entitled Johnson only to compensation for future harm he was “reasonably certain” to suffer. He had been given only two to three years to live.
R. Brent Wisner, a lawyer for Johnson, said the ruling was an overall victory but the court shouldn’t have reduced the damage award.
“This effectively rewards a defendant for killing a plaintiff, as opposed to just injuring him,” Wisner told the Chronicle.
Bayer AG, the German corporation that owns Monsanto, called the reduction “a step in the right direction” but said the appellate panel should have thrown out the verdict and said it may appeal to the California Supreme Court. |
|
|
|
|
|
|
Justice Ginsburg says cancer has returned, but won’t retire
Legal Line News |
2020/07/19 08:20
|
Justice Ruth Bader Ginsburg said Friday she is receiving chemotherapy for a recurrence of cancer, but has no plans to retire from the Supreme Court.
The 87-year-old Ginsburg, who has had four earlier bouts with cancer including pancreatic cancer last year, said her treatment so far has succeeded in reducing lesions on her liver and she will continue chemotherapy sessions every two weeks “to keep my cancer at bay.”
“I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that,” Ginsburg said in a statement issued by the court.
Ginsburg, who was appointed by President Bill Clinton in 1993, is the senior liberal justice on a court that leans conservative by a 5-4 margin. Her departure before the election could give President Donald Trump the chance to shift the court further to the right.
Ginsburg’s history with cancer goes back more than 20 years. In addition to being treated without surgery for a tumor on her pancreas last year, she also underwent surgery for colorectal cancer in 1999, pancreatic cancer in 2009 and lung cancer in December 2018.
Dr. Alan Venook, a pancreatic cancer specialist at the University of California, San Francisco, who is not involved in Ginsburg’s care, said that “clearly, she’s got incurable disease now” because of the spread to her liver.
On average, patients with advanced pancreatic cancer live about a year, but the fact that her disease took so long to recur from her initial pancreatic cancer surgery in 2009 and previous treatments “suggests that it’s not been growing rapidly,” he said.
“She’s above average in many ways.” and has done remarkably well with all her treatments so far, Venook said. “There’s no reason to think she would die imminently.”
Asked earlier this week about a possible opening on the court before the election, White House chief of staff Mark Meadows said the president would act quickly if any opening were to arise. Meadows commented after news that Ginsburg had left the hospital after receiving treatment for an infection, which she said Friday was unrelated to the cancer.
“I can’t imagine if he had a vacancy on the Supreme Court that he would not very quickly make the appointment and look for the Senate to take quick action,” Meadows said, adding that he didn’t want any comment to be seen as wishing Ginsburg “anything but the very best.”
Senate Majority Leader Mitch McConnell, R-Ky., has said that if there were to be a vacancy on the court during this year’s election cycle, the Republican-controlled Senate would likely confirm a nominee selected by Trump.
Ginsburg said she was disclosing her cancer treatment now because she is satisfied “that my treatment course is now clear.”
Venook said the chemotherapy drug Ginsburg said she is getting, gemcitabine, is one that’s often used. Immunotherapy, which Ginsburg’s statement said she tried unsuccessfully, has not worked well for pancreatic cancer, Venook said.
Ginsburg said a medical scan in February revealed growths on her liver and she began chemotherapy in May.
“My most recent scan on July 7 indicated significant reduction of the liver lesions and no new disease,” she said. “I am tolerating chemotherapy well and am encouraged by the success of my current treatment.” |
|
|
|
|
|
|
Given a chance, Trump would push court pick before election
Court News |
2020/07/18 08:20
|
President Donald Trump and Senate Majority Leader Mitch McConnell have tried to make it clear: Given the chance, they would push through a Supreme Court nominee should a vacancy occur before Election Day.
The issue has taken on new immediacy with the disclosure Friday that Justice Ruth Bader Ginsburg is receiving chemotherapy for a recurrence of cancer after four earlier bouts with the disease. The 87-year-old liberal, who apologized in 2016 for her pointed public criticism of Trump during his first campaign, says she has no plans to retire.
The development has focused even more on what's at stake this election, with the winner in position to help shape the trajectory of the court for years to come.
Trump administration officials have underscored that Trump would not hesitate to fill an opening before voters have their say Nov. 3, less than four months away, on whether to give him a second term.
Four years ago, also in a presidential election year, the GOP-controlled Senate refused to vote when President Barack Obama, a Democrat, nominated Merrick Garland, a federal judge, to succeed Justice Antonin Scalia after his death in February. Nine months before that year's election, McConnell said voters should determine who would nominate the person to fill that seat.
|
|
|
|
|
|
|
Trump tax ruling a new front in defamation suits against him
Law Firm Press |
2020/07/17 08:21
|
When the U.S. Supreme Court decided this month that the presidency isn’t a shield against a New York prosecutor’s criminal investigation, the justices didn’t say whether the same goes for civil suits against the president in state courts.
That has quickly become a question in two closely watched defamation lawsuits filed by women who say President Donald Trump smeared them while denying their sexual assault allegations.
Lawyers for the women, E. Jean Carroll and Summer Zervos, are now trying to persuade New York courts that the U.S. Supreme Court’s ruling strengthens their arguments for letting the suits go forward. Trump’s attorneys are contending just the opposite.
The dispute comes with one of the cases now before New York’s highest court, which is weighing whether a sitting president is constitutionally protected from being sued in state courts.
“The answer is no” under the U.S. Supreme Court’s reasoning, Zervos attorneys Beth Wilkinson and Moira Penza wrote in a letter Friday to the top-level state Court of Appeals.
|
|
|
|
|
|
Legal Marketing News RSS
